Neochem Bio Solutions Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	0.55	3.51	0.48	-
Cash & Short-Term Investments	0.55	3.51	0.48	-
Cash Growth	-84.33%	626.85%	-	-
Accounts Receivable	252.77	167.38	144.15	-
Other Receivables	23.89	0.18	2.79	-
Receivables	279.01	177.36	149.73	-
Inventory	237.56	182.1	149.31	-
Prepaid Expenses	3.76	4.62	1.54	-
Other Current Assets	9.91	8.29	18.8	-
Total Current Assets	530.78	375.88	319.86	-
Property, Plant & Equipment	187.12	188.22	146.95	-
Long-Term Investments	5.72	0	0.94	-
Other Intangible Assets	0.15	0.16	0.18	-
Long-Term Accounts Receivable	-	5.03	-	-
Other Long-Term Assets	65.15	65.28	38.11	-
Total Assets	788.91	634.57	506.03	-
Accounts Payable	162.96	140.99	134.07	-
Accrued Expenses	13.17	11.83	5	-
Short-Term Debt	198.85	138.87	113.45	-
Current Portion of Long-Term Debt	14.6	13.18	24.85	-
Current Income Taxes Payable	26.46	8.7	4.3	-
Other Current Liabilities	23.43	9.32	10.62	-
Total Current Liabilities	439.48	322.9	292.3	-
Long-Term Debt	142.79	181.18	124.07	-
Pension & Post-Retirement Benefits	3.1	-	1.8	-
Long-Term Deferred Tax Liabilities	6.02	7.37	7.36	-
Total Liabilities	591.39	511.45	425.52	-
Common Stock	66.75	66.75	54.26	-
Additional Paid-In Capital	14.78	14.78	14.78	-
Retained Earnings	116	41.6	11.48	-
Shareholders' Equity	197.53	123.12	80.51	-
Total Liabilities & Equity	788.91	634.57	506.03	-
Total Debt	356.24	333.23	262.37	-
Net Cash (Debt)	-355.69	-329.72	-261.89	-
Net Cash Per Share	-30.45	-49.40	-49.50	-
Filing Date Shares Outstanding	12.53	6.68	5.29	-
Total Common Shares Outstanding	6.68	6.68	5.29	-
Working Capital	91.3	52.98	27.56	-
Book Value Per Share	29.59	18.45	15.22	-
Tangible Book Value	197.38	122.96	80.33	-
Tangible Book Value Per Share	29.57	18.42	15.18	-
Land	72.34	-	31.75	-
Buildings	28.53	-	24.58	-
Machinery	141.96	-	128.05	-
Construction In Progress	0.58	-	0.41	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.